Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Radiopharm Enters into Strategic Collaboration with Lantheus and Assumes PD-L1 Licensing Agreement From Nanomab
Thursday, August 04, 2022Radiopharm Theranostics a developer of a worldclass platform of radiopharmaceutical products for both diagnostic and therapeutic uses is pleased to announce that it has entered a collaboration agreement with Lantheus for the mutually beneficial devel...
Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2
Wednesday, August 03, 2022Twist Bioscience Corporation a company enabling customers to succeed through its offering of highquality synthetic DNA using its silicon platform and Biotia Inc a company that uses proprietary analytical software for infectious disease diagnostics to...
Synthego Launches Engineered Cell Libraries to Validate Targets with Speed and Accelerate Drug Discovery
Wednesday, August 03, 2022Synthego the genome engineering company today announced the launch of Engineered Cell Libraries a novel offering that further enables access to CRISPR by providing arrayed CRISPRedited cells for direct use in functional screening assays The innovativ...
Krystal Biotech Receives FDA Acceptance of KB407 IND Application for Cystic Fibrosis Clinical Trial
Tuesday, August 02, 2022Krystal Biotech Inc the leader in redosable gene therapy today announced that the United States Food and Drug Administration FDA has accepted its Investigational New Drug IND application to evaluate KB in a clinical trial for cystic fibrosis CF KB is...
Xeris’ Commercialization Partner for Ogluo®, Tetris Pharma Ltd, to Be Acquired by Arecor Therapeutics
Tuesday, August 02, 2022Xeris Biopharma Holdings Inc a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology and neurology today announced that Tetris Pharmaits commercialization partner for Ogluo in the UK EEA an...
SyneuRx Announces Final Results of Phase 2 Clinical Trial of COVID-19 Oral Antiviral Candidate Pentarlandir® (SNB01)
Monday, August 01, 2022SyneuRx International a global biotech company focused on the development of new classes of drugs for COVID and multiple major central nervous system disorders today announced results from its phase clinical trial evaluating the efficacy and safety...
ANI Pharmaceuticals Acquires ANDAs from Oakrum Pharma, LLC
Friday, July 29, 2022ANI Pharmaceuticals Inc announced the purchase of four abbreviated new drug applications ANDAs from Oakrum Pharma LLC a privately owned biopharmaceutical company We are pleased to expand our generics product portfolio with the acquisition of four lim...
NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers Using AI and ML
Friday, July 29, 2022NeuroSense Therapeutics Ltd a company developing treatments for severe neurodegenerative diseases and NeuraLight a company developing objective and sensitive biomarkers for neurological disorders today announced a collaboration to advance the science...
MoonLake Immunotherapeutics signs development and manufacturing agreement with Vetter Pharma International GmbH
Wednesday, July 27, 2022MoonLake Immunotherapeutics AG a clinicalstage biotechnology company focused on creating nextlevel therapies for inflammatory diseases today announced that it has signed a Master Development Services Agreement with Vetter Pharma International GmbH Ve...
Sutro Biopharma Achieves “First in Human” Milestone in Cytokine Derivatives Collaboration with Merck
Wednesday, July 27, 2022Sutro Biopharma Inc a clinicalstage oncology company pioneering sitespecific and novelformat antibody drug conjugates ADCs today announced that the first patient has been dosed in a Phase study of an investigational candidate resulting from the coll...
